Investors

Growing Shareholder Value

Press Releases

Abiomed Third Quarter Fiscal 2021 Earnings and Conference Call Notification

Jan 14, 2021
Read More
Additional Formats
PDF Version

Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents

Jan 07, 2021
Read More
Additional Formats
PDF Version

Abiomed to Present at the 39th Annual J.P. Morgan Healthcare Conference

Dec 29, 2020
Read More
Additional Formats
PDF Version

First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology

Dec 21, 2020
Read More
Additional Formats
PDF Version

Two Milestones Achieved Toward Small Bore Access with Impella

Dec 15, 2020
Read More
Additional Formats
PDF Version

Abiomed to Hold Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Nov 25, 2020
Read More
Additional Formats
PDF Version

Abiomed to Hold Fireside Chat at the Stephens Annual Investment Conference 2020

Nov 11, 2020
Read More
Additional Formats
PDF Version

First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Heart Pump Designed for Surgeons

Nov 05, 2020
Read More
Additional Formats
PDF Version

Abiomed Announces Q2 FY 2021 Revenue of $210 Million, Up 27% Over Q1 FY 2021 and Up 2% Over Q2 FY 2020 With 29.2% Operating Margin

Oct 29, 2020
Read More
Additional Formats
PDF Version

First Patients Treated with the World’s Smallest Heart Pump, the 9Fr Impella ECP

Oct 28, 2020
Read More
Additional Formats
PDF Version
View all